Find information on thousands of medical conditions and prescription drugs.

Tolnaftate

Tolnaftate is a synthetic over-the-counter anti-fungal agent. It may come as a cream, powder, spray, or liquid aerosol, and is used to treat jock itch, athlete's foot and ringworm. It is sold under several brand names, most notably Tinactin.

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
Oxytetracycline
Phentermine
Tacrine
Tacrolimus
Tagamet
Talbutal
Talohexal
Talwin
Tambocor
Tamiflu
Tamoxifen
Tamsulosin
Tao
Tarka
Taurine
Taxol
Taxotere
Tazarotene
Tazobactam
Tazorac
Tegretol
Teicoplanin
Telmisartan
Temazepam
Temocillin
Temodar
Temodar
Temozolomide
Tenex
Teniposide
Tenoretic
Tenormin
Tenuate
Terazosin
Terbinafine
Terbutaline
Terconazole
Terfenadine
Teriparatide
Terlipressin
Tessalon
Testosterone
Tetrabenazine
Tetracaine
Tetracycline
Tetramethrin
Thalidomide
Theo-24
Theobid
Theochron
Theoclear
Theolair
Theophyl
Theophyl
Theostat 80
Theovent
Thiamine
Thiomersal
Thiopental sodium
Thioridazine
Thorazine
Thyroglobulin
Tiagabine
Tianeptine
Tiazac
Ticarcillin
Ticlopidine
Tikosyn
Tiletamine
Timolol
Timoptic
Tinidazole
Tioconazole
Tirapazamine
Tizanidine
TobraDex
Tobramycin
Tofranil
Tolazamide
Tolazoline
Tolbutamide
Tolcapone
Tolnaftate
Tolterodine
Tomoxetine
Topamax
Topicort
Topiramate
Tora
Toradol
Toremifene
Tracleer
Tramadol
Trandate
Tranexamic acid
Tranxene
Tranylcypromine
Trastuzumab
Trazodone
Trenbolone
Trental
Trest
Tretinoin
Triacetin
Triad
Triamcinolone
Triamcinolone hexacetonide
Triamterene
Triazolam
Triclabendazole
Triclosan
Tricor
Trifluoperazine
Trilafon
Trileptal
Trimetazidine
Trimethoprim
Trimipramine
Trimox
Triprolidine
Triptorelin
Tritec
Trizivir
Troglitazone
Tromantadine
Trovafloxacin
Tubocurarine chloride
Tussionex
Tylenol
Tyrosine
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Anti-fungal treatments grow - Bentley Pharmaceuticals, BioChemics - Brief Article
From Drug Store News, 9/10/01

It seems anti-fungal remedies will continue to drive growth in foot care. At least two companies relatively new to the OTC foot care set utilize technologies that would allow anti-fungal remedies to attack fungus at its source.

"You can't treat that disease state with a topical [remedy]," claimed Jim Murphy, president and chief executive officer of Bentley Pharmaceuticals. "The problem is it doesn't permeate." Bentley Pharmaceuticals is in the later developmental stages of a product that would penetrate an anti-fungal agent "through the nail plate and ... into the surrounding skin." This is important, according to Murphy, because although nail fungus is most visible in the nail, the problem is actually rooted within the digits.

Bentley is looking at applications for both the prescription drug and the OTC markets.

Without a consumer healthcare division of its own, Bentley will be looking to "license [the new technology] to some of the Larger, multinational companies," Murphy noted. The company hopes to have it in the market sometime next year.

"We're well into the progression of full studies," Murphy said. "The problem is in order to make a claim of total cure, you have to wait for the entire toenail or fingernail to grow out."

BioChemics currently has an athlete's foot remedy on the market, that takes advantage of its patented PentoCore transdermal drug delivery system. Containing the active ingredient tolnaftate, deFeet penetrates deep into the skin tissue and into the blood stream.

"We're really excited about deFeet in particular because the [anti-fungal] market is so fragmented," explained David Mauro, senior vice president of sales and marketing at BioChemics. "You still have a lot of customers who will bounce from product to product because of the reoccurrence of the infection."

DeFeet was test-marketed in Eckerd stores in Florida last year and has been picked up by that chain for national distribution, the company noted.

BioChemics recently kicked off a consumer ad program to support the launch, and the company has an additional foot care remedy in the works for retail launch next year.

Novartis may have sparked a marketing trend with its recent push into foot care devices that trade on the Lamasil name.

Jaime Divine, vice president of marketing at W.F. Young, makers of the Absorbine Jr. line, expressed an interest in tying the brand to a line of foot care devices.

COPYRIGHT 2001 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2001 Gale Group

Return to Tolnaftate
Home Contact Resources Exchange Links ebay